PBD Biotech

PBD Biotech is a pioneering force in biotechnology research, dedicated to advancing the detection and management of tuberculosis (TB). At the forefront of innovation, PBD Biotech has developed Actiphage, a groundbreaking blood test that identifies 'active', disease-causing tuberculosis infection. This technology holds immense potential in supporting global efforts to combat TB.

With a commitment to improving global health, PBD Biotech focuses on scaling up latent tuberculosis test-and-treat campaigns using Actiphage. The company's mission aligns with the goals of the WHO End TB strategy, aiming to drive innovation in novel uses for TB screening and drug management. PBD Biotech is located at Birmingham, B3 1RB, GB, and also has an office at 374 3rd Ave S, Saskatoon, Saskatchewan S7K 1M5, CA.

PBD Biotech continues to expand its research and development efforts, solidifying its position as a leader in TB diagnostics. The company is dedicated to making a significant impact on global TB control. PBD Biotech welcomes you to explore potential collaborations and opportunities. Management is currently adding more specific company data that will be available soon. We invite the manager of PBD Biotech to create a customized and exclusive company showcase and product listing on our platform.